Stay updated on Cabozantinib vs Everolimus in Metastatic Renal Cell Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib vs Everolimus in Metastatic Renal Cell Carcinoma Clinical Trial page.

Latest updates to the Cabozantinib vs Everolimus in Metastatic Renal Cell Carcinoma Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoChange DetectedRevision: v3.6.4 has been added, replacing the previous Revision: v3.6.3. This reflects a minor update to the page version with no changes to the study details.SummaryDifference0.0%

- Check15 days agoNo Change Detected
- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedThe page's revision tag was updated from v3.6.2 to v3.6.3, signaling a small update to the page's software or documentation.SummaryDifference0.0%

- Check37 days agoChange DetectedThe page displays an updated revision tag, changing from v3.6.0 to v3.6.2, indicating an internal update to the page.SummaryDifference0.0%

- Check52 days agoChange DetectedNew help/navigation sections were added (How to Read a Study Record, Common Questions, How to Join a Study) and the Intervention/Treatment header formatting was updated, replacing the old Intervention / Treatment and noting Revision: v3.5.5 with Revision: v3.6.0. A recruitment status update now states No longer looking for participants, indicating the study is no longer enrolling.SummaryDifference0.2%

- Check59 days agoChange DetectedRevision: v3.5.5 is now shown on the page, replacing Revision: v3.5.4 in the footer. This reflects a system update rather than changes to the study content.SummaryDifference0.0%

- Check80 days agoChange DetectedThe page now shows Revision: v3.5.4, replacing Revision: v3.5.3, indicating a software/page update rather than a change to study details.SummaryDifference0.0%

Stay in the know with updates to Cabozantinib vs Everolimus in Metastatic Renal Cell Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib vs Everolimus in Metastatic Renal Cell Carcinoma Clinical Trial page.